UBS Group AG - BELLICUM PHARMACEUTICALS INC ownership

BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 78 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 9.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BELLICUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$56,000
+47.4%
43,417
+18.9%
0.00%
Q3 2019$38,000
+22.6%
36,520
+98.7%
0.00%
Q2 2019$31,000
-58.1%
18,377
-17.2%
0.00%
Q1 2019$74,000
-42.2%
22,203
-49.1%
0.00%
Q4 2018$128,000
+11.3%
43,655
+132.3%
0.00%
Q3 2018$115,000
-7.3%
18,789
+12.3%
0.00%
Q2 2018$124,000
+275.8%
16,731
+233.6%
0.00%
Q1 2018$33,000
-25.0%
5,015
-5.0%
0.00%
Q4 2017$44,000
-75.3%
5,280
-65.6%
0.00%
Q3 2017$178,000
+42.4%
15,367
+43.4%
0.00%
Q2 2017$125,000
+635.3%
10,714
+665.3%
0.00%
Q1 2017$17,000
+30.8%
1,400
+45.4%
0.00%
Q4 2016$13,000
-80.9%
963
-71.7%
0.00%
Q3 2016$68,000
+119.4%
3,400
+41.5%
0.00%
Q2 2016$31,000
+342.9%
2,403
+243.3%
0.00%
Q1 2016$7,000
-30.0%
700
+40.0%
0.00%
Q4 2015$10,000
-65.5%
500
-74.8%
0.00%
Q3 2015$29,000
+163.6%
1,985
+297.0%
0.00%
Q2 2015$11,000
-60.7%
500
-57.9%
0.00%
Q1 2015$28,000
-92.9%
1,188
-93.1%
0.00%
Q4 2014$397,00017,2070.00%
Other shareholders
BELLICUM PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
EMORY UNIVERSITY 95,215$1,297,0001.28%
Baker Brothers Advisors 4,865,647$66,270,0000.65%
Eventide Asset Management 250,000$3,405,0000.22%
MCDANIEL TERRY & CO 76,112$1,037,0000.22%
SUFFOLK CAPITAL MANAGEMENT LLC 82,538$1,124,0000.15%
QVT Financial LP 337,923$4,603,0000.14%
KENNEDY CAPITAL MANAGEMENT LLC 478,465$6,517,0000.11%
Vident Investment Advisory, LLC 47,157$642,0000.08%
Tekla Capital Management LLC 60,000$817,0000.04%
First Eagle Investment Management, LLC 775,254$10,559,0000.03%
View complete list of BELLICUM PHARMACEUTICALS INC shareholders